FDA Advisers Approve Novavax Covid-19 Vaccine

During a meeting yesterday, vaccine advisers with the FDA decided that authorizing Novavax’s COVID-19 vaccine for emergency use in adults would be beneficial. The Novavax vaccine will be given as a two-dose primary series and uses different technology from the three vaccines that the United States is currently using. During the vote, 21 members voted yes, 1 abstained and none voted no. This vaccines is made using small laboratory-built pieces of the Coronavirus to stimulate immunity. If the FDA gives the green light, it will become the fourth vaccine authorized for use in the United States.